Top Tweets for #miThingsAB
@chiatticarlos just made his pitch presenting #MAGICGLASS and our fantastic journey from clinical trials in @MagicPcp to market at @Innolabs_EU #Healthcare_Demo_Day_19! #INNOLABSUPPORTSME Thanks also to @UlsterUni #miThingsAB @EEN_Italia @EUScienceInnov https://t.co/7CfWrE1hdm

@soo_cchsc @MagicPcp @UnivPoliMarche @UlsterUni Sure! We are almost ready also in Belfast, thanks to the precious support by @HSCBoard, @UlsterUni, Prof. @smcdonough2 at @UlsterUniLHS, Dr. @DarrylCharles at @SceisUni, #miThingsAB, and our team at #Tech4Care led by @chiatticarlos
Proud to have been awarded together with our lead partner #miThingsAB by the @Innolabs_EU 2nd Open Call! We will advance together our #VRRelief prototype for chronic #pain management, developed within the @RELIEFprojectEU PCP https://t.co/4DGHTrg5tB
Awarded SMEs from the 2nd Open Call of @Innolabs_EU are meeting their KAMs and the innovative services that the Consortium can offer them

Another important award for #Tech4Care, @UlsterINHR & #miThingsAB! Our #MAGICGLASS project for #stroke rehabilitation, based on a virtual reality (#VR) system, received funding under @MagicPcp for conducting clinical trials in Italy and Northern Ireland! Phase 3 is coming!
Phase 3 supplier information now available on the MAGIC-PCP website at https://t.co/xJjwUCkz6x
#magicpcp
#Tech4Care is excited that our #DiaWatch project will proceed with prototype development thanks to @ProEmpowerPCP Phase 2! Working with #miThingsAB, @lifeina_ & #Meteda for a solution improving #diabetes type 2 management #mHealth #DigitalHealth #AI https://t.co/qxGumXazep

We are finalizing the prototype of #VRRELIEF! The virtual doctor developed by #Tech4Care is almost ready to be tested and to support self-management and treatment of chronic #pain. Funded by @RELIEFprojectEU https://t.co/t0G9Y6442a #mHealth #DigitalHealth @UlsterINHR #miThingsAB

#Tech4Care is glad of being selected for @ProEmpowerPCP Phase 1! We are already working hard together with our partners #miThingsAB, #Lifeina and #Meteda on the #DiaWatch solution for innovating #diabetes management and care
https://t.co/J1SKXlGOUB https://t.co/zjlOR3knct
Congratulations to the companies selected to continue to the next phase of ProEmpower PCP! Find out who they are: https://t.co/2kKQ9Zx36P
#Tech4care, @UlsterUni and #miThingsAB were in #Paris and #Uppsala this week for two important @RELIEFprojectEU meetings. Good discussion and feedback with staff at hospitals #HôpitalLariboisière and @Akademiska_Nytt on our new solution for managing chronic #pain.

#Tech4Care is really excited for this award! Ready to start working on our #VR_RELIEF solution for #ChronicPain by exploiting potential of #VirtualReality #VR with our partners @UlsterUni #miThingsAB @HospitalRibera https://t.co/k8nevIlWnG
Consult the resolution of the Buyer’s Group! Congrats to awarded! Thank you all for participate! https://t.co/YzzUjJ3EEY

Last Seen Hashtags on Sotwe
Pegging
Seen from Germany
ConnectGroups
Seen from United States
incestowithmom
Seen from India
dogknotting
Seen from United States
婊子
Seen from Sweden
anxiouspanda
Seen from United States
croffeepot
Seen from United States
nazillibayan
Seen from Turkey
parejacaliente
Seen from Turkey
mom
Seen from India
Most Popular Users

Elon Musk 
@elonmusk
241.7M followers

Barack Obama 
@barackobama
119M followers

Cristiano Ronaldo 
@cristiano
114.5M followers

Donald J. Trump 
@realdonaldtrump
111.9M followers

Narendra Modi 
@narendramodi
107.2M followers

Rihanna 
@rihanna
98.7M followers

NASA 
@nasa
92.4M followers

Justin Bieber 
@justinbieber
91.8M followers

KATY PERRY 
@katyperry
90M followers

Taylor Swift 
@taylorswift13
84M followers

Lady Gaga 
@ladygaga
75.4M followers

Virat Kohli 
@imvkohli
73.4M followers

Kim Kardashian 
@kimkardashian
70.9M followers

YouTube 
@youtube
68.8M followers

Neymar Jr 
@neymarjr
66.4M followers

Bill Gates 
@billgates
65.2M followers

Selena Gomez 
@selenagomez
63.1M followers

The Ellen Show
@theellenshow
62.3M followers

CNN 
@cnn
61.8M followers

X 
@x
60.7M followers





